Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Melcher

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Iscience|January 25, 2024
DNA-PKcs is required for cGAS/STING-dependent viral DNA sensing in human cellsDayana B Hristova, Marisa Oliveira, Emma Wagner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2009
Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidityPaul Hatfield, Mohan Hingorani, Ganesh Radhakrishna, et al.
FEBS Letters|March 6, 2007
Expression of the CUB domain containing protein 1 (CDCP1) gene in colorectal tumour cellsSara E Perry, Philip Robinson, Alan Melcher, et al.
Cancer Gene Therapy|May 4, 2018
Synergistic antitumour effects of rapamycin and oncolytic reovirusCharles Comins, Guy Richard Simpson, William Rogers, et al.
Cancer Immunology, Immunotherapy : CII|March 8, 2011
International symposium on CTL and immunostimulation, Pamplona (Spain), October 26th and 27th 2010Maria C Ochoa, Sandra Hervas-Stubbs, Asis Palazon, et al.
Molecular Cancer|February 23, 2011
Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune primingLynette Steele, Fiona Errington, Robin Prestwich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapyFiona Errington, Andrew Bateman, Tim Kottke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 16, 2010
The effect of cell cycle synchronization on tumor sensitivity to reovirus oncolysisLucy Heinemann, Guy R Simpson, Nicola E Annels, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
Killing of normal melanocytes, combined with heat shock protein 70 and CD40L expression, cures large established melanomasLuis Sanchez-Perez, Timothy Kottke, Gregory A Daniels, et al.
Molecular Therapy Oncolytics|March 5, 2021
Oncolytic Reovirus-Mediated Recruitment of Early Innate Immune Responses Reverses Immunotherapy Resistance in Prostate TumorsNicola E Annels, Guy R Simpson, Mick Denyer, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Iscience|January 25, 2024
DNA-PKcs is required for cGAS/STING-dependent viral DNA sensing in human cellsDayana B Hristova, Marisa Oliveira, Emma Wagner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2009
Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidityPaul Hatfield, Mohan Hingorani, Ganesh Radhakrishna, et al.
FEBS Letters|March 6, 2007
Expression of the CUB domain containing protein 1 (CDCP1) gene in colorectal tumour cellsSara E Perry, Philip Robinson, Alan Melcher, et al.
Cancer Gene Therapy|May 4, 2018
Synergistic antitumour effects of rapamycin and oncolytic reovirusCharles Comins, Guy Richard Simpson, William Rogers, et al.
Cancer Immunology, Immunotherapy : CII|March 8, 2011
International symposium on CTL and immunostimulation, Pamplona (Spain), October 26th and 27th 2010Maria C Ochoa, Sandra Hervas-Stubbs, Asis Palazon, et al.
Molecular Cancer|February 23, 2011
Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune primingLynette Steele, Fiona Errington, Robin Prestwich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapyFiona Errington, Andrew Bateman, Tim Kottke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 16, 2010
The effect of cell cycle synchronization on tumor sensitivity to reovirus oncolysisLucy Heinemann, Guy R Simpson, Nicola E Annels, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
Killing of normal melanocytes, combined with heat shock protein 70 and CD40L expression, cures large established melanomasLuis Sanchez-Perez, Timothy Kottke, Gregory A Daniels, et al.
Molecular Therapy Oncolytics|March 5, 2021
Oncolytic Reovirus-Mediated Recruitment of Early Innate Immune Responses Reverses Immunotherapy Resistance in Prostate TumorsNicola E Annels, Guy R Simpson, Mick Denyer, et al.
Pageof 14